Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs

Regorafenib resistance is a key limiting factor in the treatment of advanced hepatocellular carcinoma (HCC). Increasing evidence has demonstrated that Berberine (BBR) can synergistically enhance the therapeutic effect of various chemotherapeutic agents. However, the contribution of BBR on regorafeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kunyuan, Yu, Ganxiang, Lin, Jiaen, Wang, Zhilei, Lu, Qianting, Gu, Chengxin, Yang, Tao, Liu, Shiming, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248669/
https://www.ncbi.nlm.nih.gov/pubmed/34220494
http://dx.doi.org/10.3389/fphar.2021.632201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248669/
https://www.ncbi.nlm.nih.gov/pubmed/34220494
http://dx.doi.org/10.3389/fphar.2021.632201

Ejemplares similares